World Market of Carcinoembryonic Antigen and Forecast by 2023| Broadcast MRFR
The report gives detail analysis of the market structure along with forecast, market size & share, different segments and developing trends of the industry.
Carcinoembryonic Antigen Market –Overview
Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/772
In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.
Carcinoembryonic Antigen Market –Major Key Players
- Lee BioSolutions
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated.
- Correlogic Systems, Inc
- Genway Biotech, Inc.
- Abbott.
- RayBiotech, Inc.
- Abcam plc.
- Biocare Medical, LLC
- Biocare Medical, LLC.
Carcinoembryonic Antigen Market -Regional Analysis
The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.
For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772
Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.
Carcinoembryonic Antigen Market -Segmentation
The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.
Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.
Major Points form TOC for Carcinoembryonic Antigen Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Carcinoembryonic Antigen Market, By Type
Chapter 7. Global Carcinoembryonic Antigen Market, By Treatment
Chapter 8 Global Carcinoembryonic Antigen Market, By End User
Chapter 9. Global Carcinoembryonic Antigen Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Feel Free to Ask Any Query @ https://www.marketresearchfuture.com/enquiry/772
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com